Cancer Supportive Care: Oral Palonosetron Approved in EU

The Second Generation 5-HT3 Receptor Antagonist Palonosetron, Already Approved as an Intravenous Solution Formulation in More Than 60 Countries Worldwide Including US, EU and Japan, Obtains the European Marketing Authorization for 0.5 mg Oral Capsules

LUGANO, Switzerland, May 10, 2010 – Palonosetron 0.5 mg soft gelatine capsule oral formulation has been
approved by the EMA (European [...]

Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.

Global Acquisition Expands Ferring's Role in Women's Health
SAINT-PREX, Switzerland, May 10, 2010 – Ferring Pharmaceuticals today announced an agreement that will expand its
Women's Health product portfolio with the acquisition of the global rights to
Xanodyne Pharmaceutical's LYSTEDA(TM) (tranexamic acid), a first-in-class,
non-hormonal therapy indicated specifically for treatment of women with
cyclic heavy menstrual bleeding (HMB). The company [...]

Health Robotics’ i.v.STATION Certified as the Only Robot to Comply with Security Guidelines for Controlled Substances

BOZEN, SUD-TIROL, Italy, May 10, 2010 – Health Robotics today announced i.v.STATION's certification achieving
compliance with a host of global security guidelines for controlled
substances, including tamper-evident syringe caps, biometric identification,
restricting nursing access only to ready-to-administer IVs, single-dose
storage and retrieval, etc.

"In addition to being the only company in the world proven to [...]

Lizann Prosser, Former Deloitte Director, Named New President of Crown Agents USA, Inc.

WASHINGTON, May 10, 2010 – Crown Agents USA, Inc. (CA-USA) is pleased to announce that Lizann
Prosser, former senior manager of Deloitte's Health and Social Protection
Practice, has been chosen as president of Crown Agents USA. She assumed her
new post in April 2010 becoming the CA-USA president and chief executive
officer.

Ms. Prosser is [...]

Epix Pharmaceuticals, Inc. Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-2104R MRI Imaging Agent

WELLESLEY HILLS, Massachusetts, May 10, 2010 – Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee for the Benefit of
Creditors of Epix Pharmaceuticals, Inc. ("Epix"), announced today that the
MRI imaging intellectual properties of the EP-2104R MRI imaging agent, which
will be auctioned on May 28, 2010, include potential revenue sharing from the
first commercial sale of non-MRI imaging [...]

Gates Foundation Funds 78 New Innovative Global Health Projects Including Cell Phone Blood Tests, Carnivorous Plants and Sweat-Triggered Vaccines

Grants From 18 Countries Poised to Help Prevent and Diagnose Infectious Disease and Promote Family Health

LONDON, May 11, 2010 – The Bill & Melinda Gates Foundation today announced 78 grants of
US$100,000 each in the latest round of Grand Challenges Explorations. Grants
include the development of a low-cost cell phone microscope to diagnose
malaria, study of the [...]